List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Intercept Pharmaceuticals Company

Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.

Headquarters: United States
Founded Date: 2002
Employee Number: 501-1000
Estimated Revenue: $50M to $100M
Industry: Metabolism Dysfunctions
Technology: Cancer
Funding Status: IPO